PharmCADD

General Information

Company Name

PharmCADD

Founded Year

2019

Location (Offices)

Korea South +1

Founders / Decision Makers

Number of Employees

Industries

AI, Biotechnology, Pharmaceutical

Funding Stage

Series B

Social Media

PharmCADD - Company Profile

PharmCADD, founded in 2019 and headquartered in Korea South, is at the forefront of accelerating drug discovery through the integration of AI and Molecular Dynamics Simulation. The company's platform harnesses cutting-edge technologies such as AI, Molecular Dynamics (MD), Quantum Calculation (QC), and Network theory to streamline drug design and discovery processes. This approach not only expedites drug candidate searches within the vast chemical space using AI, but also enables more precise characterization of potential drug candidates through MD and quantum calculation. PharmCADD's recent $16.00M Series B investment on 19 April 2021, led by DSC Investment, KTB Network, DAYLI Partners, Maple Investment Partners, KDB Capital, KB Securities, Huons, DAOL Investment, and SD Group, underlines the confidence of investors in the company's innovative approach, positioning it as a key player in the Biotechnology and Pharmaceutical industries.

Taxonomy: drug discovery, Molecular Dynamics Simulation, Quantum Calculation, Network theory, protein structure prediction, MD simulation, vaccine development, data-derived technology, physics-based technology, toxicity prediction, virtual screening, pharmaceuticals